Scleral Lenses Market Set for Robust Expansion, Projected to Reach USD 323.5 Million by 2032

The global market for scleral lenses is witnessing a significant upswing, with a projected compound annual growth rate (CAGR) of 6.3% over the next decade. According to a recent report by Future Market Insights, the market is set to grow from a valuation of USD 175.5 million in 2022 to approximately USD 323.5 million by 2032, driven by increasing demand for advanced and comfortable vision correction solutions.

Scleral lenses—large-diameter, gas-permeable lenses—are specifically designed to cover the entire corneal surface and rest on the sclera (the white part of the eye), offering enhanced stability and comfort for wearers. Unlike traditional contact lenses, scleral lenses create a tear-filled vault over the cornea, making them ideal for patients with complex ocular conditions or sensitive eyes.

Stay Updated with Market Movements: Get Your Sample Report! https://www.futuremarketinsights.com/report-sample#5245502d47422d3130323437

Rising Preference for Mini Scleral Lenses

Among the various product categories, mini scleral lenses emerged as the dominant segment in 2021, accounting for approximately 47.4% of the global market share. Their relatively smaller size makes them easier to fit and more comfortable for daily use while still offering the advantages of standard scleral lenses, such as oxygen permeability and exceptional tear exchange.

These lenses are particularly useful in managing ocular conditions like keratoconus, pellucid marginal degeneration, neurotrophic keratitis, microphthalmia, and dry eye syndrome, along with corneal scarring and other irregularities. As awareness of scleral lenses as a treatment modality grows, both older adults and younger patients are increasingly opting for them, especially those with intolerance to traditional lenses.

Technological Innovations Driving Market Growth

One of the key factors propelling the scleral lenses market is the influx of technological innovations aimed at enhancing lens performance, fitting accuracy, and wearer comfort.

• In December 2021, BostonSight introduced its Smart360 design software, revolutionizing the customization of scleral lenses through precise data-driven lens creation.
• In November 2021, CooperVision Specialty EyeCare announced improved pupil optics for its Onefit MED and MED+ scleral lenses, offering better visual acuity and comfort.

These innovations reflect a broader industry trend toward customized, patient-centric solutions, which are becoming central to competitive strategies in the ophthalmic devices space.

Key Takeaways:

USA: Dominating the Scleral Lenses Market in North America

The USA leads the North American scleral lenses market with a revenue of about USD 69.09 million, driven by the increasing prevalence of eye disorders such as keratoconus. With an estimated 50 to 200 cases per 100,000 people, the demand for scleral lenses continues to grow, ensuring a strong market outlook.

Germany: A Technologically Advanced and Lucrative Market

In Europe, Germany holds a significant market share of 44.7% as of 2021. The country’s market growth is propelled by advancements in eye care technology, including improved lens design, topography measurements, and high-tech materials. These innovations have led to broader adoption of scleral lenses in Germany, making it a key player in the market.

India: Rapid Growth in South Asia

India accounted for 59.8% of the South Asian scleral lenses market in 2021 and is poised for rapid growth. This is attributed to advancements in medical technology, government support for eye care, and a growing patient base due to the rising population and increasing eye diseases. The market in India is expected to expand significantly over the forecast period.

Mini Scleral Lenses: Key Growth Driver

Mini scleral lenses are expected to grow at a CAGR of 4.9%, contributing around USD 79.2 million to the global market in 2021. These lenses, known for their safety, comfort, and effectiveness in treating corneal irregularities, are gaining popularity and contributing to the market’s overall growth.

Corneal Irregularities: The Leading Indication for Scleral Lenses

Corneal irregularities, including conditions like keratoconus and pellucid marginal degeneration, are the primary indications addressed by scleral lenses. With an estimated global market value of USD 82.2 million in 2021, the treatment of corneal irregularities remains the most common application for scleral lenses, driving the demand in the global market.

High Demand for Market Insights: Discover Comprehensive Trends in Our Full Report! https://www.futuremarketinsights.com/reports/scleral-lenses-market

Competitive Landscape: Mergers, Collaborations & Expansions

Key players in the scleral lenses market are actively pursuing strategic initiatives such as mergers and acquisitions, partnerships, product innovations, and geographic expansions to strengthen their foothold in the global market. Companies are leveraging R&D capabilities and digital technologies to optimize lens design and meet the specific needs of patients with complex eye conditions.

Notable companies in the global scleral lenses market include:

• CooperVision
• Bausch & Lomb
• Visionary Optic (Euclid Systems)
• Art Optical Contact Lens, Inc.
• AccuLens
• Valley Contax Inc.
• ABB Optical Group
• EssilorLuxottica
• Solotica
• Optact International Ltd.
• Smart Optics LLC
• Gelflex
• Biolens Lab
• Metro Optics, among others.

These companies are not only introducing cutting-edge technologies but are also expanding access through better distribution channels and specialized practitioner training.

Segmental Overview

By Product Type:

• Mini Scleral Lenses
• Semi Scleral Lenses
• Large Scleral Lenses

Mini scleral lenses dominate due to ease of adaptation and widespread clinical application. However, other segments are also showing promising growth as demand diversifies.

By Indication:

• Corneal Irregularity
• Surface Ocular Disease
• Refractive Error
• Other Indications

The use of scleral lenses for corneal irregularities remains the largest application area, but increasing cases of dry eye disease and complex post-surgical eye conditions are creating new growth avenues.

By Region:

• North America continues to lead the market due to advanced healthcare infrastructure, high awareness, and early technology adoption.
• Europe follows closely, driven by rising prevalence of keratoconus and supportive reimbursement policies.
• East Asia, South Asia, Latin America, Oceania, and MEA are emerging as high-potential markets due to improving healthcare access and increasing diagnosis of vision disorders.

Future Outlook

The future of the scleral lenses market looks promising, bolstered by:

• Increased prevalence of ocular surface diseases.
• Growing geriatric population with specific vision care needs.
• Expanding application in pediatric ophthalmology.
• Greater customization through digital eye imaging and AI-based lens fitting.
• Improved practitioner training and awareness campaigns.

In addition, advancements in 3D printing, hybrid lens materials, and tele-optometry are poised to reshape the landscape of specialty contact lenses, making scleral lenses more accessible and effective for a broader patient base.

Conclusion

As the demand for specialized, high-comfort vision correction grows, the global scleral lenses market is positioned for sustained expansion. With mini scleral lenses leading the charge and innovation driving adoption across diverse demographic groups, key stakeholders—including manufacturers, eye care professionals, and investors—have a significant opportunity to capitalize on this growing sector.